216 related articles for article (PubMed ID: 25264749)
1. Saxagliptin restores vascular mitochondrial exercise response in the Goto-Kakizaki rat.
Keller AC; Knaub LA; Miller MW; Birdsey N; Klemm DJ; Reusch JE
J Cardiovasc Pharmacol; 2015 Feb; 65(2):137-47. PubMed ID: 25264749
[TBL] [Abstract][Full Text] [Related]
2. Novel repair mechanisms in a renal ischaemia/reperfusion model: Subsequent saxagliptin treatment modulates the pro-angiogenic GLP-1/cAMP/VEGF, ANP/eNOS/NO, SDF-1α/CXCR4, and Kim-1/STAT3/HIF-1α/VEGF/eNOS pathways.
Kamel NM; Abd El Fattah MA; El-Abhar HS; Abdallah DM
Eur J Pharmacol; 2019 Oct; 861():172620. PubMed ID: 31437429
[TBL] [Abstract][Full Text] [Related]
3. Exercise training enhanced myocardial endothelial nitric oxide synthase (eNOS) function in diabetic Goto-Kakizaki (GK) rats.
Grijalva J; Hicks S; Zhao X; Medikayala S; Kaminski PM; Wolin MS; Edwards JG
Cardiovasc Diabetol; 2008 Nov; 7():34. PubMed ID: 19019231
[TBL] [Abstract][Full Text] [Related]
4. Vildagliptin stimulates endothelial cell network formation and ischemia-induced revascularization via an endothelial nitric-oxide synthase-dependent mechanism.
Ishii M; Shibata R; Kondo K; Kambara T; Shimizu Y; Tanigawa T; Bando YK; Nishimura M; Ouchi N; Murohara T
J Biol Chem; 2014 Sep; 289(39):27235-27245. PubMed ID: 25100725
[TBL] [Abstract][Full Text] [Related]
5. NOS isoform-specific regulation of basal but not exercise-induced mitochondrial biogenesis in mouse skeletal muscle.
Wadley GD; Choate J; McConell GK
J Physiol; 2007 Nov; 585(Pt 1):253-62. PubMed ID: 17916611
[TBL] [Abstract][Full Text] [Related]
6. Effects of long-term treatment with the dipeptidyl peptidase-4 inhibitor vildagliptin on islet endocrine cells in non-obese type 2 diabetic Goto-Kakizaki rats.
Inaba W; Mizukami H; Kamata K; Takahashi K; Tsuboi K; Yagihashi S
Eur J Pharmacol; 2012 Sep; 691(1-3):297-306. PubMed ID: 22820107
[TBL] [Abstract][Full Text] [Related]
7. Clinical Pharmacokinetics and Pharmacodynamics of Saxagliptin, a Dipeptidyl Peptidase-4 Inhibitor.
Boulton DW
Clin Pharmacokinet; 2017 Jan; 56(1):11-24. PubMed ID: 27282159
[TBL] [Abstract][Full Text] [Related]
8. Erectile dysfunction in young non-obese type II diabetic Goto-Kakizaki rats is associated with decreased eNOS phosphorylation at Ser1177.
Carneiro FS; Giachini FR; Carneiro ZN; Lima VV; Ergul A; Webb RC; Tostes RC
J Sex Med; 2010 Nov; 7(11):3620-34. PubMed ID: 20807325
[TBL] [Abstract][Full Text] [Related]
9. Endothelial dysfunction in the early- and late-stage type-2 diabetic Goto-Kakizaki rat aorta.
Kazuyama E; Saito M; Kinoshita Y; Satoh I; Dimitriadis F; Satoh K
Mol Cell Biochem; 2009 Dec; 332(1-2):95-102. PubMed ID: 19543853
[TBL] [Abstract][Full Text] [Related]
10. Dipeptidyl peptidase-4 inhibition improves cardiac function in experimental myocardial infarction: Role of stromal cell-derived factor-1α.
Connelly KA; Advani A; Zhang Y; Advani SL; Kabir G; Abadeh A; Desjardins JF; Mitchell M; Thai K; Gilbert RE
J Diabetes; 2016 Jan; 8(1):63-75. PubMed ID: 25565455
[TBL] [Abstract][Full Text] [Related]
11. The effects of dipeptidyl-peptidase-IV inhibitor, vildagliptin, on the exocrine pancreas in spontaneously diabetic Goto-Kakizaki rats.
Mizukami H; Inaba W; Takahashi K; Kamata K; Tsuboi K; Yagihashi S
Pancreas; 2013 Jul; 42(5):786-94. PubMed ID: 23774700
[TBL] [Abstract][Full Text] [Related]
12. Differential Mitochondrial Adaptation in Primary Vascular Smooth Muscle Cells from a Diabetic Rat Model.
Keller AC; Knaub LA; McClatchey PM; Connon CA; Bouchard R; Miller MW; Geary KE; Walker LA; Klemm DJ; Reusch JE
Oxid Med Cell Longev; 2016; 2016():8524267. PubMed ID: 27034743
[TBL] [Abstract][Full Text] [Related]
13. Impaired response to exercise intervention in the vasculature in metabolic syndrome.
Knaub LA; McCune S; Chicco AJ; Miller M; Moore RL; Birdsey N; Lloyd MI; Villarreal J; Keller AC; Watson PA; Reusch JE
Diab Vasc Dis Res; 2013 May; 10(3):222-38. PubMed ID: 23162060
[TBL] [Abstract][Full Text] [Related]
14. Saxagliptin reduces renal tubulointerstitial inflammation, hypertrophy and fibrosis in diabetes.
Gangadharan Komala M; Gross S; Zaky A; Pollock C; Panchapakesan U
Nephrology (Carlton); 2016 May; 21(5):423-31. PubMed ID: 26375854
[TBL] [Abstract][Full Text] [Related]
15. Losartan improves aortic endothelium-dependent relaxation via proline-rich tyrosine kinase 2/Src/Akt pathway in type 2 diabetic Goto-Kakizaki rats.
Nemoto S; Kobayashi T; Taguchi K; Matsumoto T; Kamata K
Am J Physiol Heart Circ Physiol; 2011 Dec; 301(6):H2383-94. PubMed ID: 21926342
[TBL] [Abstract][Full Text] [Related]
16. Critical role of renal dipeptidyl peptidase-4 in ameliorating kidney injury induced by saxagliptin in Dahl salt-sensitive hypertensive rats.
Sakai M; Uchii M; Myojo K; Kitayama T; Kunori S
Eur J Pharmacol; 2015 Aug; 761():109-15. PubMed ID: 25936515
[TBL] [Abstract][Full Text] [Related]
17. Saxagliptin prevents vascular remodeling and oxidative stress in db/db mice. Role of endothelial nitric oxide synthase uncoupling and cyclooxygenase.
Solini A; Rossi C; Duranti E; Taddei S; Natali A; Virdis A
Vascul Pharmacol; 2016 Jan; 76():62-71. PubMed ID: 26455387
[TBL] [Abstract][Full Text] [Related]
18. Dipeptidyl peptidase-4 inhibition with saxagliptin enhanced nitric oxide release and reduced blood pressure and sICAM-1 levels in hypertensive rats.
Mason RP; Jacob RF; Kubant R; Ciszewski A; Corbalan JJ; Malinski T
J Cardiovasc Pharmacol; 2012 Nov; 60(5):467-73. PubMed ID: 22932707
[TBL] [Abstract][Full Text] [Related]
19. The DPP-4 inhibitor saxagliptin ameliorates ox-LDL-induced endothelial dysfunction by regulating AP-1 and NF-κB.
Ma S; Bai Z; Wu H; Wang W
Eur J Pharmacol; 2019 May; 851():186-193. PubMed ID: 30639312
[TBL] [Abstract][Full Text] [Related]
20. The dipeptidyl peptidase-4 inhibitor saxagliptin improves function of circulating pro-angiogenic cells from type 2 diabetic patients.
Poncina N; Albiero M; Menegazzo L; Cappellari R; Avogaro A; Fadini GP
Cardiovasc Diabetol; 2014 May; 13():92. PubMed ID: 24886621
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
